Skip to main content
OCS logo
OCS
(NASDAQ)
Oculis Holding AG
$26.63-- (--)
Loading... - Market loading

Oculis Holding (OCS) Stock Price & Financial Analysis

Oculis Holding Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$26.08 - $27.00
52-Week High$30.68
52-Week Low$14.00
Open$26.41
Volume109.78K
Average Volume (3M)109.78K
Market Cap1.39B
Shares Outstanding52.36M
Price to Sales (P/S)2242.66
Price to Book (P/B)5.76
EV/EBITDA-11.02
Revenue (TTM)629.80K
Net Income (TTM)-123.43M
Free Cash Flow (TTM)-83.88M
EPS (TTM)$-2.20
Profit Margin-19598.87%
Operating Margin-16254.38%
Return on Equity (ROE)-50.32%
Debt to Equity0.01
50-Day MA$27.40
200-Day MA$21.26
52-Week Change44.86%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Oculis Holding

What is the current stock price for OCS?

As of the latest trading session, OCS stock trades at $26.63. The 52-week range is $14.00–$30.68, with a day range of $26.07–$27.00.

What is the P/E ratio for OCS?

The P/E ratio (Price-to-Earnings) for OCS is shown in the Key Statistics section. This valuation metric helps compare Oculis Holding AG to industry peers.

Does OCS pay dividends?

Oculis Holding does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OCS?

Based on 3 analysts, the consensus for OCS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OCS?

Oculis Holding's market capitalization is $1.39B, classifying it as a small-cap company. Oculis Holding operates in the Healthcare sector within the Biotechnology industry.